Bioline Rx reported $-2.21M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Arca Biopharma USD -25.09M 5.23M Mar/2025
Bio Path USD -3.24M 616K Mar/2025
Bioline Rx USD -2.21M 96K Sep/2025
Capricor Therapeutics USD -24.98M 17.28M Mar/2025